Societal CDMO, Inc. (NASDAQ:SCTL) Q1 2023 Earnings Conference Call May 10, 2023 4:30 PM ET
Company Participants
Stephanie Diaz - President & CEO, Vida Strategic Partners Inc.
David Enloe - President, CEO & Director
Ryan Lake - SVP & CFO
Conference Call Participants
Matthew Hewitt - Craig-Hallum
Maxwell Smock - William Blair & Company
Steven Etoch - Stephens Inc.
Marla Marin - Zacks Small-Cap Research
Operator
Good day, ladies and gentlemen, and welcome to the Societal CDMO First Quarter 2023 Financial Results Conference Call. [Operator Instructions].
I would now like to hand the conference over to Stephanie Diaz of Societal's Investor Relations group. Please go ahead.
Stephanie Diaz
Thank you. Hello, and thank you for joining us. On today's call, we have David Enloe, President and CEO; and Ryan Lake, Chief Financial Officer. Today, we will be providing an overview of Societal contract development and manufacturing business, including updates on corporate activities and financial results for the quarter ended March 31, 2023.
After our prepared remarks, we will welcome your questions. Before we begin, I'd like to caution that comments made during this conference call today May 10, 2023, will contain certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 concerning the current beliefs of the company, which involve a number of assumptions, risks and uncertainties.
Actual results could differ from these statements, and the company undertakes no obligation to revise or update any statement made today.
I encourage you to review all of the company's filings with the Securities and Exchange Commission concerning these and other matters. Our earnings press release and this call will include discussion of certain non-GAAP information. You can find our earnings press release, including relevant non-GAAP reconciliations on our corporate website at societalcdmo.com.
With that, I will turn the call over to David Enloe, Societal's President and CEO.
David Enloe
Thank you, Stephanie, and thank you to everyone participating today via webcast. As reported during our March webcast, 2022 was a transformative year for Societal, and we have been pleased to ride the momentum created into the first quarter of 2023, despite the overall headwinds our industry is experiencing.
Since the beginning of 2023, we have announced multiple new business wins, including new customer wins as well as the expansion of work with multiple existing clients.
During the period, we were also very pleased to announce the FDA's approval of Societal's first commercially manufactured tablet product, an important expansion of our capabilities that extends beyond the company's long-standing expertise in commercial capsule production.